Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
08/1995
08/01/1995CA1336528C Antimalarial amnioquinoline derivatives, process for their preparation and pharmaceutical composition containing them
08/01/1995CA1336516C Acyl derivatives of 2-amino-4-substituted-5-hydroxy pyrimidines
08/01/1995CA1336514C Cyclo-octane neuroprotective agents
08/01/1995CA1336506C Method for protection from chemotherapeutic side effects
08/01/1995CA1336505C L-carnitine enriched pet food
08/01/1995CA1336504C Photodynamic therapeutic technique
08/01/1995CA1336503C Use of 5-heteroaryl- or 5-aryl-substituted imidazo[2,1-a] isoquinolines
08/01/1995CA1336502C Nasal administration of benzodiazepine hypnotics
08/01/1995CA1336501C Method of preventing or reducing venous thrombosis using a thromboxane a- receptor antagonist in conjunction with heparin and combination
08/01/1995CA1336500C Opthalmic suspensions
08/01/1995CA1336494C Emulsions of highly fluorinated organic compounds
08/01/1995CA1336492C Treatment of genital warts with a combination of podophyllin and recombinant dna human alpha interferon
08/01/1995CA1336491C Antiviral pharmaceutical composition
08/01/1995CA1336490C Pharmacological treatment of ocular development
08/01/1995CA1336488C Dosage form having reduced abuse potential
07/1995
07/29/1995CA2141256A1 Antitumor agent, novel 3(2h)-pyridazinone derivatives and their preparation
07/29/1995CA2140952A1 Combination treatment for osteoporosis
07/29/1995CA2139549A1 Corticoid derivatives and pharmaceutical and cosmetic compositions
07/28/1995CA2141277A1 Method for preparing thioether conjugates
07/28/1995CA2141176A1 Ophthalmic composition
07/27/1995WO1995019983A1 Watersoluble azole antifungals
07/27/1995WO1995019980A1 Pyrrolopyridazine derivative
07/27/1995WO1995019979A1 Improved process for synthesizing carbapenem intermediates
07/27/1995WO1995019978A1 Tetracyclic derivatives, process of preparation and use
07/27/1995WO1995019970A1 Tricyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
07/27/1995WO1995019968A1 Aromatic 2-amino-imidazole derivatives as alpha-2a adrenoceptor agonists
07/27/1995WO1995019965A1 Synthetic matrix metalloprotease inhibitors and uses thereof
07/27/1995WO1995019964A1 Ep2-receptor agonists as agents for lowering intraocular pressure
07/27/1995WO1995019963A1 New pharmacotherapeutically active compounds
07/27/1995WO1995019961A1 Metalloproteinase inhibitors
07/27/1995WO1995019960A1 Monoamine oxidase b inhibitors, processes for their preparation and use thereof
07/27/1995WO1995019959A1 Amino acid derivatives and their use as phospholipase a2 inhibitors
07/27/1995WO1995019958A1 Malarial aspartic protease inhibitors
07/27/1995WO1995019957A1 Hydroxamic acid derivatives as metalloproteinase inhibitors
07/27/1995WO1995019956A1 Metalloproteinase inhibitors
07/27/1995WO1995019952A1 Nitroxy group-containing benzylamine derivatives and their use for treating cardiovascular diseases, as well as increased intra-ocular pressure
07/27/1995WO1995019778A1 Peritoneal dialysis solutions containing maltodextrins and amino acids
07/27/1995WO1995019777A2 Use of diesters of muramyl peptides in oral form as immunostimulating agents
07/27/1995WO1995019776A1 A method of treating glaucoma
07/27/1995WO1995019775A1 A pharmaceutical composition with improved bio-availability of inositol phosphate
07/27/1995WO1995019774A1 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
07/27/1995WO1995019773A1 Carbostyril oxytocin receptor antagonists
07/27/1995WO1995019772A1 Use of bis(amidinobenzimidazoles) in the manufacture of medicament for inhibiting retroviral integrase
07/27/1995WO1995019771A1 Indole diterpene alkaloid compounds
07/27/1995WO1995019770A1 Methods and compositions for treating androgen-dependent diseases using optically pure r-(-)-casodex
07/27/1995WO1995019769A1 Combinations of a creatine compound with a hyperplastic inhibitory agent for inhibiting undesirable cell growth
07/27/1995WO1995019768A1 Use of amino acids for the treatment and prophylaxis of pathogenic effect caused by intracellular calcium overload
07/27/1995WO1995019767A1 Guanylhydrazones for treating inflammatory conditions
07/27/1995WO1995019766A1 Benzalkonium fluoride injectable solution
07/27/1995WO1995019765A1 Certain cerulenin-geranyl and dodecanoic acid derivatives
07/27/1995WO1995019764A1 Cis-hydroxyproline analogs for eye treatment
07/27/1995WO1995019760A1 Oral composition
07/27/1995WO1995019758A1 Hair-care composition
07/27/1995WO1995019706A1 Inhibitors of fatty acid synthesis as antimicrobial agents
07/27/1995WO1995019705A1 Intravenous administration of psoralen
07/27/1995WO1995017875A3 MIXTURES OF DIDEOXYNUCLEOSIDES AND D-ASPARTIC ACID β-HYDROXAMATE FOR INHIBITING RETROVIRAL SPREAD
07/27/1995WO1995009848A3 Polyazacycloalkanes as dichelants
07/27/1995CA2181923A1 Use of amino acids for the treatment and prophylaxis of pathogenic effect caused by intracellular calcium overload
07/27/1995CA2181899A1 Use of diesters of muramyl peptides in oral form as immunostimulating agents
07/27/1995CA2181885A1 Benzalkonium fluoride injectable solution
07/27/1995CA2181788A1 Cis-hydroxyproline analogs for eye treatment
07/27/1995CA2181725A1 Oral composition
07/27/1995CA2181709A1 Hydroxamic acid derivatives as metalloproteinase inhibitors
07/27/1995CA2181581A1 Nitroxy group-containing benzylamine derivatives and their use for treating cardiovascular diseases, as well as increased intra-ocular pressure
07/27/1995CA2181551A1 Malarial aspartic protease inhibitors
07/27/1995CA2181449A1 A method of treating glaucoma
07/27/1995CA2181371A1 Indole diterpene alkaloid compounds
07/27/1995CA2181358A1 Methods and compositions for treating androgen-dependent diseases using optically pure r-(-)-casodex
07/27/1995CA2181031A1 Inhibitors of fatty acid synthesis as antimicrobial agents
07/27/1995CA2180956A1 Monoamine oxidase b inhibitors, processes for their preparation and use thereof
07/27/1995CA2178935A1 Improved process for synthesizing carbapenem intermediates
07/27/1995CA2177372A1 Bicyclic compounds capable of inhibiting tyrosine kinases of the epidermal growth factor receptor family
07/27/1995CA2158760A1 Synthetic matrix metalloprotease inhibitors and uses thereof
07/27/1995CA2156733A1 Peritoneal dialysis solutions containing maltodextrins and amino acids
07/26/1995EP0664297A1 Use of cyclic Didepsipeptides having 12 ring atoms to control endoparasites, novel cyclic depsipeptides with 12 ring atoms and process for their synthesis
07/26/1995EP0664294A1 Production of nucleoside analogues
07/26/1995EP0664291A1 Pyrimidine compound
07/26/1995EP0664290A1 Mono- and di-esters of cinnamic acid or of one of his derivatives and of vitamine C, their process of preparation and their use as antioxydants in cosmetic, pharmaceutical or alimentary compositions
07/26/1995EP0664289A2 Isoquinolines
07/26/1995EP0664287A1 Vitamin D Compounds and method of preparing these compounds
07/26/1995EP0664282A1 Biaryl phospholipase A2 inhibitors
07/26/1995EP0664130A1 External preparation for treating hemorrhoidal diseases
07/26/1995EP0664129A2 Epicholesterol for treating dyslipidemia
07/26/1995EP0664128A1 Pharmaceutical composition for inhibiting tumor necrosis factor production
07/26/1995EP0664127A2 Pharmaceutical compositions containing isoquinoline derivatives
07/26/1995EP0664126A1 Inhibition of thrombin
07/26/1995EP0664125A1 Inhibition of myeloperoxidase activity
07/26/1995EP0664124A1 Treatment of atrophy of the skin and vagina
07/26/1995EP0664123A1 Inhibition of autoimmune diseases
07/26/1995EP0664122A1 Inhibition of imperfect tissue repair
07/26/1995EP0664121A1 Inhibition of ldl oxidation and atherosclerosis
07/26/1995EP0664120A1 Device for the vaginal administration of tamoxifen and its analogs
07/26/1995EP0664117A1 Liposome solutions
07/26/1995EP0664111A2 Biospecific emulsions
07/26/1995EP0663958A1 Inhibition of cyst formation by cytoskeletal specific drugs
07/26/1995EP0663919A1 Pyrimidine bisphosphonate esters as anti-inflamatories
07/26/1995EP0663918A1 Pure enantiomers of phosphoric-acid esters as phospholipase-a2 inhibitors
07/26/1995EP0663916A1 O-alkylated rapamycin derivatives and their use, particularly as immunosuppressants
07/26/1995EP0663914A1 Process for the preparation of 9-amino camptothecin
07/26/1995EP0663912A1 Heterocyclic ether compounds that enhance cognitive function
1 ... 6998 6999 7000 7001 7002 7003 7004 7005 7006 7007 7008 7009 7010 7011 7012 7013 7014 7015 7016 7017 7018 ... 7860